In our study, the GSEA results suggested that elevated KIF4A, KIF18A, and KIF23 levels in LGG and GBM patients are correlated with E2F transcription factor activity, the G2M checkpoint, Myc targets, and the mitotic spindle. The gene discussed is KIF18A; the disease is glioblastoma.